Disc Medicine(IRON.US) Director Sells US$9,253.3 in Common Stock
$Disc Medicine(IRON.US)$ Director White William Richard sold 201 shares of common stock on Jul 1, 2024 at an average price of $46.0363 for a total value of $9,253.3.Source: Announcement What is statem
Bitfarms Technologies, Vestis, and More Stocks See Action From Activist Investors -- Barrons.com
These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequen
Disc Medicine Insider Bought Shares Worth $3,000,024, According to a Recent SEC Filing
Mona Ashiya, Director, on June 17, 2024, executed a purchase for 83,334 shares in Disc Medicine (IRON) for $3,000,024. Following the Form 4 filing with the SEC, Ashiya has control over a total of 235,
Stifel Maintains Disc Medicine(IRON.US) With Buy Rating, Raises Target Price to $79
Stifel analyst Benjamin Burnett maintains $Disc Medicine(IRON.US)$ with a buy rating, and adjusts the target price from $72 to $79.According to TipRanks data, the analyst has a success rate of 35.3% a
BMO Capital Maintains Disc Medicine(IRON.US) With Buy Rating, Cuts Target Price to $50
BMO Capital analyst Evan Seigerman maintains $Disc Medicine(IRON.US)$ with a buy rating, and adjusts the target price from $70 to $50.According to TipRanks data, the analyst has a success rate of 0.0%
BMO Capital Reiterates Outperform on Disc Medicine, Raises Price Target to $70
BMO Capital analyst Evan Seigerman reiterates Disc Medicine (NASDAQ:IRON) with a Outperform and raises the price target from $50 to $70.
Express News | Disc Medicine Inc : Wedbush Raises Target Price to $57 From $43
A Quick Look at Today's Ratings for Disc Medicine(IRON.US), With a Forecast Between $57 to $70
On Jun 15, major Wall Street analysts update their ratings for $Disc Medicine(IRON.US)$, with price targets ranging from $57 to $70.BMO Capital analyst Evan Seigerman maintains with a buy rating, and
S&P 500 Edges Lower; RH Shares Plunge After Q1 Results
U.S. stocks traded mixed toward the trading, with the Dow Jones index falling around 0.2% on Friday.The Dow traded down 0.24% to 38,554.69 while the NASDAQ rose 0.07% to 17,680.01. The S&P 500 also fe
Wedbush Raises Disc Medicine Price Target to $57 From $43, Maintains Outperform Rating
Disc Medicine (IRON) has an average rating of outperform and price targets ranging from $40 to $85, according to analysts polled by Capital IQ. Price: 46.14, Change: +6.98, Percent Change: +17.81
Disc Medicine On Track for Largest Percent Increase Since December 2022-- Data Talk
Disc Medicine, Inc. (IRON) is currently at $47.40, up $8.25 or 21.05% --Would be highest close since March 28, 2024, when it closed at $62.26 --On pace for largest percent increase since Dec. 30, 20
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of AMMO, Inc. (NASDAQ:POWW) fell sharply during Friday's session following fourth-quarter results.AMMO reported a fourth-quarter profit of 1 cent per share, compared to market expectations for
12 Health Care Stocks Moving In Friday's Intraday Session
GainersCyclerion Therapeutics (NASDAQ:CYCN) shares moved upwards by 37.4% to $2.9 during Friday's regular session. The market value of their outstanding shares is at $7.2 million. CNS Pharma (NASDAQ:C
Disc Medicine +17%, Prices $178 Million Common Stock Offering; Shares Rise
Disc Medicine (IRON) said Friday that it has priced an underwritten offering of about 4.9 million common shares at $36 per share for expected gross proceeds of about $178 million. Net proceeds will be
Gold Gains 1%; US Consumer Sentiment Falls In June
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 200 points on Friday.The Dow traded down 0.63% to 38,403.11 while the NASDAQ fell 0.07% to 17,655.10. The S&
Disc Medicine Shares Jump 18% After Latest Aurora Clinical Trial Data
By Sabela Ojea Shares of Disc Medicine on Friday jumped after the company said it received positive data from its phase 2 clinical trial Aurora to treat erythropoietic protoporphyria with ibitopertin
Express News | Disc Medicine Shares Are Trading Higher. The Company Announced the Presentation of Data at the European Hematology Association 2024 Congress and Announced an Underwritten Offering
Disc Medicine Price Target Maintained With a $70.00/Share by HC Wainwright & Co.
Disc Medicine Price Target Maintained With a $70.00/Share by HC Wainwright & Co.
Hasbro, Tutor Perini, Arm Holdings And Other Big Stocks Moving Higher On Friday
U.S. stocks were mostly lower, with the Dow Jones index falling around 300 points on Friday.Shares of Hasbro, Inc. (NASDAQ:HAS) rose sharply during Friday's session after B of A Securities upgraded th
Express News | Disc Medicine Announces $178M Underwritten Offering Of 4.944M Shares At $36/Share